Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
St. john's wort dry extract (as dry extract) from st. john's wort aerial part (hypericum perforatum l)
Holland & Barrett International Limited
St. john's wort dry extract (as dry extract) from st. john's wort aerial part (hypericum perforatum l)
.
Capsule, hard
Product not subject to medical prescription
Not marketed
2016-11-11
HYPERICUM HARD CAPSULES, ST. JOHN’S WORT EXTRACT More information on back panel P A T I E N T I N F O R M A T I O N L E A F L E T IMPORTANT NOTES Please read this leaflet carefully before you use this traditional herbal medicine because it contains important information for you: • Always take this traditional herbal medicine exactly as described in this leaflet or as your doctor or pharmacist has told you • Keep this leaflet, you may need to read it again • Ask a healthcare professional e.g. a doctor or a pharmacist if you need more information or advice • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4 • You must talk to a doctor if you feel worse or if you do not feel better after 4 weeks of taking this traditional herbal medicine WHAT IS IN THIS LEAFLET 1 What this traditional herbal medicine is and what it is used for 2 What you need to know before you take this traditional herbal medicine 3 How to take this traditional herbal medicine 4 Possible side effects 5 How to store this traditional herbal medicine 6 Further information 1 - WHAT THIS TRADITIONAL HERBAL MEDICINE IS AND WHAT IT IS USED FOR This traditional herbal medicine contains St. John’s Wort (_Hypericum perforatum _L.) Extract. It is a traditional herbal medicinal product used to relieve the symptoms of slightly low mood in adults, exclusively based upon long-standing use. 2 - WHAT YOU NEED TO KNOW BEFORE YOU TAKE THIS TRADITIONAL HERBAL MEDICINE Do not take this traditional herbal medicine if: • You are allergic to St. John’s Wort or any of the ingredients in this traditional herbal medicinal product (listed in Section 6 of this leaflet). • You are taking any of the medicines listed in the table below • You are taking medicines for depression or migraine • You are taking medicines to suppress your immune system after transplant surgery • You are pregnant or breastfeeding • You have skin that is sensitive to sunlight or are Read the complete document
Health Products Regulatory Authority 20 January 2020 CRN009KHR Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nature’s Bounty Hypericum Hard Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains 284 mg of extract (as dry extract) from St. John’s Wort aerial parts (Hypericum perforatum L.) (5-7:1), corresponding to: 0.3 – 0.9 mg of total hypericins; not less than 18 mg of flavonoids, expressed as rutin; maximum 1 mg hyperforin. Extraction solvent: ethanol 60% v/v. For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Capsule, hard Clear, hard, two piece capsules with green brown fill. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS A traditional herbal medicinal product used to relieve the symptoms of slightly low mood in adults, exclusively based upon long-standing use. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral short term use only. ADULTS ANDOLDER PEOPLE: Take 1 capsule daily. Swallow the whole capsule with water. DURATION OF USE: If symptoms worsen or persist after 4 weeks of using the medicinal product, a qualified healthcare professional e.g. a doctor or pharmacist should be consulted. St John’s wort should not be used in the treatment of children and adolescents under the age of 18 years (see section 4.4). 4.3 CONTRAINDICATIONS Hypersensitivity to St. John’s wort or any of the excipients listed in section 6.1 This product should not be taken concomitantly with any of the medicines specified in section 4.5. This is because St. John’s wort ( _Hypericum perforatum _ ) has been shown to induce the cytochrome P450 isoenzymes CYP1A2, CYP2C9, CYP2C19 and CYP3A4 as well as the transport protein, P-gycoprotein. This results in pharmacokinetic interactions with a large number of medicines including a possible decrease in the effectiveness of those medicines Clinically significant pharmacodynamic interactions have been identified with the SSRI antidepressants and the triptan group of medicines used to treat migr Read the complete document